AGTR2 and glioma: EMA401 (angiotensin II type 2 receptor antagonist) inhibits angiogenesis and the proliferation/invasion of glioma cells, and its A3E derivative reduces tumor volume, inhibits tumor cell proliferation, and augments apoptotic mechanisms in gliomas [19].